Pfizer is expected to announce on Monday that it will combine its off-patent drug business with Mylan, the generics drugmaker with a market value of $9.5bn, ...
Pfizer and Mylan set to merge off-patent drugs businesses - Financial Times
Read More
Pfizer is expected to announce on Monday that it will combine its off-patent drug business with Mylan, the generics drugmaker with a market value of $9.5bn, ...
Editor’s Note: A version of this story appears in CNN’s Meanwhile in today’s Middle East newsletter, a three-times-a-week look inside the r...
No comments:
Post a Comment